Ha-Won Jeong

Title: Ha-Won Jeong: Innovator in Cancer Treatment

Introduction

Ha-Won Jeong is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of compounds that may aid in cancer treatment. His innovative work focuses on the preparation of specific chemical compounds that exhibit inhibitory activities against critical processes involved in cancer progression.

Latest Patents

Ha-Won Jeong holds a patent for "8-Acetylarteminolide and process for preparing same." This compound, represented by the formula (I), has shown promising inhibitory activities against farnesyl-protein transferase (FPTase), which is crucial in the progression of the cell cycle and angiogenesis. The potential applications of this compound may be beneficial in the prevention and treatment of various cancers and diseases related to angiogenesis. He has 1 patent to his name.

Career Highlights

Ha-Won Jeong is affiliated with the Korea Research Institute of Bioscience and Biotechnology. His work at this esteemed institution has allowed him to explore innovative solutions in the realm of cancer research. His dedication to advancing scientific knowledge and developing effective treatments is evident in his research endeavors.

Collaborations

Some of his notable coworkers include Byoung-Mog Kwon and Kwang-Hee Son. Their collaborative efforts contribute to the advancement of research in biotechnology and cancer treatment.

Conclusion

Ha-Won Jeong's contributions to the field of biotechnology, particularly through his patent on 8-Acetylarteminolide, highlight his commitment to finding innovative solutions for cancer treatment. His work continues to inspire advancements in medical research and therapeutic development.